Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Javier Mora Robles"'
Autor:
Antonio Ignacio Cuesta-Vargas, Iván José Fuentes-Abolafio, Celia García-Conejo, Estíbaliz Díaz-Balboa, Manuel Trinidad-Fernández, Daniel Gutiérrez-Sánchez, Adrián Escriche-Escuder, Lidia Cobos-Palacios, Almudena López-Sampalo, Jose Maria Pérez-Ruíz, Cristina Roldán-Jiménez, Miguel Angel Pérez-Velasco, Javier Mora-Robles, Mª Dolores López-Carmona, David Pérez-Cruzado, Jaime Martín-Martín, Luis Miguel Pérez-Belmonte
Publikováno v:
BMC Cardiovascular Disorders, Vol 23, Iss 1, Pp 1-11 (2023)
Abstract Background Patients with heart failure with preserved ejection fraction (HFpEF) have a low functional status, which in turn is a risk factor for hospital admission and an important predictor of survival in HFpEF. HFpFE is a heterogeneous syn
Externí odkaz:
https://doaj.org/article/947c777909e5412c94cdb01aeaec153f
Autor:
Elisabeth Gómez-Moyano, Javier Pavón-Morón, Jorge Rodríguez-Capitán, Daniel Bardán-Rebollar, Teresa Ramos-Carrera, Aurora Villalobos-Sánchez, Iván Pérez de Pedro, Francisco J. Ruiz-García, Javier Mora-Robles, Almudena López-Sampalo, Miguel A. Pérez-Velasco, Maria-Rosa Bernal-López, Ricardo Gómez-Huelgas, Manuel Jiménez-Navarro, Miguel Romero-Cuevas, Francesco Costa, Alicia Trenas, Luis M. Pérez-Belmonte
Publikováno v:
Journal of Clinical Medicine, Vol 13, Iss 8, p 2405 (2024)
The therapeutic management and short-term consequences of the coronavirus disease 2019 (COVID-19) are well known. However, COVID-19 post-acute sequelae are less known and represent a public health problem worldwide. Patients with COVID-19 who present
Externí odkaz:
https://doaj.org/article/bb9d74d4764b46bcb79162a3661f1aac
Autor:
Ana I. Molina-Ramos, Elisabeth Gómez-Moyano, Jorge Rodríguez-Capitán, María Angullo-Gómez, Patricia Gallardo-Jiménez, Iván Pérez de Pedro, Lucía Valiente de Santis, Beatriz Pérez-Villardón, Isabel Piñero-Uribe, Javier Mora-Robles, Víctor Manuel Becerra-Muñoz, Manuel Jiménez-Navarro
Publikováno v:
Journal of Clinical Medicine, Vol 11, Iss 23, p 6999 (2022)
The coronavirus disease of 2019 (COVID-19) has been a cause of significant morbidity and mortality worldwide. Among the short- and long-term consequences of COVID-19, myocarditis is a disease to be taken into consideration. Myocarditis, in general, i
Externí odkaz:
https://doaj.org/article/60998c88192146cf91389365af855300
Autor:
C. M. Nneji, Praveen D. Chaudhari, Biswajit Dash, Maria João Sousa, P. U. Bassi, Ruby A. Ynalvez, Atul A. Phatak, Oksana Sintsova, Olívia R. Pereira, Mohannad Qurie, Margarita Monastyrnaya, Keiko Suzuki, Juan Manuel Lacal Peña, Laura Scrano, Adnan Manassra, Luís Pedro, Rosa Fernández Olmo, Enrique Otero Chulian, A. Kwaji, H. K. Manonmani, Kassandra L. Compean, Elena Leychenko, Jan Tytgat, Emma Kozlovskaya, Rafael Colman Llamozas, H. B. Kavya, Sachin U. Kushare, Robin Broussard, S. Alexandar, Masahiro Nagaoka, Irina Gladkikh, Ashok Kumar Sah, Giulio Tarro, Mustafa Khamis, G. Ademowo, Javier Mora Robles, Marina Isaeva, Ibrahim Ayyad, Md. Mahamood, M. Vijaysimha, Rafik Karaman, Alfred Addo-Mensah, Shumpei Niida, Ai Thu Thi Nguyen, Elena Zelepuga, Steve Peigneur, Rashmi S. Shenoy, Valentin Tabakmakher, Paula Dias, Juana Delgado Pacheco, M. Aqill, Kate Vincent, S. R. Ashwinirani, Sabino A. Bufo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::42e860c181cf984b8b06b9af517ac492
https://doi.org/10.9734/bpi/tprd/v6
https://doi.org/10.9734/bpi/tprd/v6